Shingles vaccine candidate strongly immunogenic in a Phase 3 trial

被引：0

|

作者：

不详

机构：

来源：

HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2017年 / 13卷 / 08期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：1734 / 1734

页数：1

相关论文

共 50 条

[1] New Shingles Vaccine on the horizon after successful Phase 3 Trial
不详
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (02) : 311 - 311
[2] Shingles vaccine trial
Stephenson, J
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07): : 625 - 625
[3] Clinical trial for shingles vaccine begins final phase
Cimons, M
ASM NEWS, 1999, 65 (10): : 670 - 671
[4] Shingles vaccine candidate efficacious in the elderly
不详
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (11) : 2720 - 2721
[5] Marburg Vaccine Safe, Immunogenic in Phase 1 Trial
Harris, Emily
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (09): : 703 - 703
[6] A 'universal' RSV vaccine was immunogenic in a Phase 2 trial
不详
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (08) : 1734 - 1734
[7] Peanut allergy therapeutic vaccine candidate has entered Phase 3 trial
不详
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (03) : 558 - 558
[8] RSV vaccine candidate immunogenic in older people
不详
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (09) : 1958 - 1958
[9] Clostridium difficile vaccine candidate safe and immunogenic
不详
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (02) : 263 - 263
[10] GSK's shingles vaccine starts phase 3 in immunocompromised patients
Riedmann, Eva M.
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (09) : 1169 - 1170

← 1 2 3 4 5 →